
NanoVibronix NAOV
Annual report 2025
added 04-15-2026
NanoVibronix P/S Ratio 2011-2026 | NAOV
Annual P/S Ratio NanoVibronix
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 0.036 | 0.0592 | 6.42 | 0.606 | 16.8 K | 36.7 | 67.9 | 98 | 120 | 64.6 | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 16.8 K | 0.036 | 1.72 K |
P/S Ratio of other stocks in the Medical devices industry
| Issuer | P/S Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Apollo Endosurgery
APEN
|
5.24 | - | - | $ 475 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
5.44 | - | - | $ 1.77 B | ||
|
Aziyo Biologics
AZYO
|
1.09 | - | 1.37 % | $ 20.5 M | ||
|
Electromed
ELMD
|
2.73 | $ 25.34 | -2.61 % | $ 214 M | ||
|
AdaptHealth Corp.
AHCO
|
0.371 | $ 12.98 | -2.99 % | $ 1.75 B | ||
|
Allied Healthcare Products
AHPI
|
0.667 | - | 3.58 % | $ 2.21 M | ||
|
Avinger
AVGR
|
0.339 | - | -20.74 % | $ 369 K | ||
|
BIOLASE
BIOL
|
0.0039 | - | -13.19 % | $ 166 K | ||
|
Lianluo Smart Limited
LLIT
|
409 | - | 24.59 % | $ 44.8 M | ||
|
Axonics Modulation Technologies
AXNX
|
10.3 | - | - | $ 3.31 B | ||
|
BioSig Technologies
BSGM
|
183 | - | 37.08 % | $ 85.7 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
22 | - | -5.86 % | $ 30.6 M | ||
|
EDAP TMS S.A.
EDAP
|
5.1 | $ 3.3 | -0.15 % | $ 124 M | ||
|
Conformis
CFMS
|
0.204 | - | - | $ 16.4 M | ||
|
Helius Medical Technologies
HSDT
|
5.5 | $ 1.97 | -5.28 % | $ 1.2 M | ||
|
Cardiovascular Systems
CSII
|
2.49 | - | 0.15 % | $ 844 M | ||
|
Cytosorbents Corporation
CTSO
|
0.94 | $ 0.64 | 7.43 % | $ 39.8 M | ||
|
ClearPoint Neuro
CLPT
|
8.55 | $ 10.17 | -8.21 % | $ 288 M | ||
|
Dynatronics Corporation
DYNT
|
0.0712 | - | 14.99 % | $ 929 K | ||
|
Globus Medical
GMED
|
4.24 | $ 88.1 | -2.88 % | $ 11.9 B | ||
|
Eargo
EAR
|
0.456 | - | - | $ 10.2 M | ||
|
CryoLife, Inc.
CRY
|
3.58 | - | -4.14 % | $ 702 M | ||
|
Second Sight Medical Products
EYES
|
44.4 K | - | -0.97 % | $ 54.4 M | ||
|
CHF Solutions, Inc.
CHFS
|
0.19 | - | 1.15 % | $ 34.5 M | ||
|
GBS
GBS
|
0.812 | - | -0.57 % | $ 7.12 M | ||
|
Pulmonx Corporation
LUNG
|
0.805 | $ 1.2 | -2.45 % | $ 48.8 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
1.88 K | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
8.25 | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
2.96 | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
266 | - | - | $ 111 M | ||
|
Orthofix Medical
OFIX
|
0.598 | $ 11.47 | -3.69 % | $ 454 M | ||
|
Butterfly Network
BFLY
|
9.34 | $ 4.89 | -5.15 % | $ 1.04 B | ||
|
Intersect ENT, Inc.
XENT
|
9.12 | - | - | $ 955 M | ||
|
Insulet Corporation
PODD
|
6.7 | $ 162.26 | -11.27 % | $ 11.4 B | ||
|
OrthoPediatrics Corp.
KIDS
|
1.85 | $ 14.66 | -3.2 % | $ 344 M | ||
|
Delcath Systems
DCTH
|
3.83 | $ 10.15 | -3.79 % | $ 364 M | ||
|
IRIDEX Corporation
IRIX
|
0.315 | $ 1.03 | -0.96 % | $ 17.4 M | ||
|
Sintx Technologies
SINT
|
6.78 | $ 2.01 | -6.74 % | $ 5.57 M | ||
|
CONMED Corporation
CNMD
|
0.959 | $ 35.42 | -3.71 % | $ 1.1 B | ||
|
LivaNova PLC
LIVN
|
2.74 | $ 59.11 | -3.56 % | $ 3.22 B | ||
|
Inspire Medical Systems
INSP
|
1.93 | $ 52.89 | -4.0 % | $ 1.55 B | ||
|
LENSAR
LNSR
|
1.22 | $ 5.33 | -0.47 % | $ 63.7 M | ||
|
Integer Holdings Corporation
ITGR
|
1.61 | $ 83.35 | -1.57 % | $ 2.9 B | ||
|
Invacare Corporation
IVC
|
0.133 | - | - | $ 24.7 M | ||
|
Edwards Lifesciences Corporation
EW
|
8.05 | $ 81.31 | -1.18 % | $ 47.6 B | ||
|
TELA Bio
TELA
|
0.404 | $ 0.83 | 6.01 % | $ 39 M | ||
|
Tandem Diabetes Care
TNDM
|
4.35 | $ 17.72 | -4.88 % | $ 1.21 B | ||
|
Tactile Systems Technology
TCMD
|
1.94 | $ 22.41 | -4.92 % | $ 513 M | ||
|
Stryker Corporation
SYK
|
22.8 | $ 312.54 | -2.78 % | $ 119 B |